Phase I/II Clinical Radioimmunotherapy with an Iodine-131 -Labeled Anti-Carcinoembryonic Antigen

in normal and tumor tissue. Metabolism 1990;30(supp] 2):78-81. 16. Reubi JC, Kvols L, Krenning EP. Lamberts SWJ. In vivo in vitro detection of somatostatin receptors in human malignant tissues. Ada Oncnl 1991:30:463-468. 17. Krenning EP. Kwekkeboom DJ, de Jong M, et a!. Essential of peptide receptor scintigraphy with emphasis on the somatostatin analog octreotide. Semin Oncol 1994:21:6-14. 18. Lamberts SWJ, Reubi JC. Krenning EP. Somatostatin and the concept of peptide receptor scintigraphy in oncology. Semin Oncol 1994;21:l-5. 19. Lamberts SWJ. Chayvialle J-A. Krenning EP. The visualization of gaslroenteropancreatic tumors. Metabolism 1992;9(suppl): 111-115. 20. Kwekkeboom DJ, Krenning EP. Bakker WH. et al. Somatostatin receptor scintigraphy in carcinoid tumors. Ear J NucÃ-Med 1993:20:283-292. 21. Kvols LK. Brown ML, O'Connor MK, et al. Evaluation of a radiolabeled somatostatin

[1]  P. Flamen,et al.  Visualizing ocular melanoma using iodine-123-N-(2-diethylaminoethyl)4-iodobenzamide SPECT. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  M. Juweid,et al.  Variables influencing tumor dosimetry in radioimmunotherapy of CEA-expressing cancers with anti-CEA and antimucin monoclonal antibodies. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  M. Juweid,et al.  Dosimetric potential of minimal residual disease using radiolabeled antibodies , 1996 .

[4]  D. Goldenberg,et al.  Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors. , 1996, Cancer research.

[5]  I. Bernstein,et al.  Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas , 1995, The Lancet.

[6]  G. Hortobagyi,et al.  Phase I clinical and pharmacological study of suppression of human antimouse antibody response to monoclonal antibody L6 by deoxyspergualin. , 1995, Cancer research.

[7]  C. Reiners,et al.  Radioiodine therapy of Graves' hyperthyroidism: standard vs. calculated 131 iodine activity * . Results from a prospective, randomized, multicentre study , 1995, European journal of clinical investigation.

[8]  D. Goldenberg.  Cancer Therapy with Radiolabeled Antibodies , 1994 .

[9]  M. Juweid,et al.  PRECLINICAL AND CLINICAL EVALUATION OF A CDR-GRAFTED (HUMANIZED) ANTI-CARCINOEMBRYONIC ANTIGEN (CEA) MONOCLONAL ANTIBODY (MAb) , 1994 .

[10]  J. Schlom,et al.  Treatment of metastatic prostate carcinoma with radiolabeled antibody CC49. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  F. Grunert,et al.  A repertoire of monoclonal antibodies reveals extensive epitope heterogeneity in CEA purified from neoplasms originating from different organs , 1994, International journal of cancer.

[12]  D. Goldenberg,et al.  Comparison of equitoxic radioimmunotherapy and chemotherapy in the treatment of human colonic cancer xenografts. , 1994, Cancer research.

[13]  R. V. Van Heertum,et al.  Colorectal cancer imaging with iodine-123-labeled CEA monoclonal antibody fragments. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  S. Kennel,et al.  Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodies. , 1992, Cancer research.

[15]  J. Weinstein,et al.  Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier. , 1992, Cancer research.

[16]  M. Schwartz.  Lactic dehydrogenase. An old enzyme reborn as a cancer marker? , 1991, American journal of clinical pathology.

[17]  J. Jessup,et al.  The structure, metabolism and function of the carcinoembryonic antigen gene family. , 1990, Biochimica et biophysica acta.

[18]  D. Goldenberg,et al.  Murine monoclonal antibodies against carcinoembryonic antigen: immunological, pharmacokinetic, and targeting properties in humans. , 1990, Cancer research.

[19]  D. Goldenberg,et al.  Evaluation of a remote radioiodination system for radioimmunotherapy. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  D. Goldenberg,et al.  Tumor, red marrow, and organ dosimetry for 131I-labeled anti-carcinoembryonic antigen monoclonal antibody. , 1990, Cancer research.

[21]  R. DeJager,et al.  Human immune response to anti-carcinoembryonic antigen murine monoclonal antibodies. , 1990, Cancer research.

[22]  Cancer Imaging with Radiolabeled Antibodies , 1990, Cancer Treatment and Research.

[23]  R. E. Lee,et al.  Sacral scintigraphy for bone marrow dosimetry in radioimmunotherapy. , 1989, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[24]  R K Jain,et al.  Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure. , 1988, Cancer research.

[25]  D. Goldenberg,et al.  "Sandwich"-type immunoassay of carcinoembryonic antigen in patients receiving murine monoclonal antibodies for diagnosis and therapy. , 1988, Clinical chemistry.

[26]  R. K. Wu,et al.  Absolute quantitation of radioactivity using the buildup factor. , 1984, Medical physics.

[27]  D. Goldenberg,et al.  Immunological heterogeneity of carcinoembryonic antigen: antigenic determinants on carcinoembryonic antigen distinguished by monoclonal antibodies. , 1983, Cancer research.

[28]  J R van Nagell,et al.  Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. , 1978, The New England journal of medicine.

[29]  C. Milstein,et al.  Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.

[30]  Z. Bentwich,et al.  Carcinoembryonic Antigen , 1978 .